Frazier Life Sciences Management, L.P.

Frazier Life Sciences Management, L.P. reported 44 holdings worth US$4.03B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Frazier Life Sciences Management, L.P. reported 44 holdings worth US$4.03B as of Sep 30, 2026. Largest: Mirum Pharmaceuticals, Inc., Erasca, Inc. and MBX Biosciences, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
44
Value as reported
US$4.03B

The filing in full

CompanySharesValue as reported% of portfolio
Mirum Pharmaceuticals, Inc.7.68MUS$656M16.3%
Erasca, Inc.29.5MUS$432M10.7%
MBX Biosciences, Inc.6.65MUS$390M9.7%
Arcutis Biotherapeutics, Inc.9.87MUS$261M6.5%
Maze Therapeutics, Inc.5.28MUS$144M3.6%
Trevi Therapeutics, Inc.9.54MUS$137M3.4%
Krystal Biotech, Inc.391KUS$130M3.2%
Palvella Therapeutics, Inc.882KUS$122M3.0%
Attovia Therapeutics, Inc.7.05MUS$121M3.0%
Braveheart Bio, Inc.5.27MUS$106M2.6%
Phathom Pharmaceuticals, Inc.12.5MUS$91M2.3%
Parabilis Medicines, Inc.2.33MUS$75.3M1.9%
Dyne Therapeutics, Inc.3.85MUS$62.1M1.5%
Achieve Life Sciences, Inc.7.61MUS$61.6M1.5%
MannKind Corporation15.8MUS$61.4M1.5%
Disc Medicine, Inc.935KUS$61.2M1.5%
Tarsus Pharmaceuticals, Inc.720KUS$56.6M1.4%
Vor Biopharma Inc.2.74MUS$52.4M1.3%
Zai Lab Ltd.1.9MUS$50.1M1.2%
Aclaris Therapeutics, Inc.8.73MUS$45.9M1.1%
Aura Biosciences, Inc.7.1MUS$44.6M1.1%
Allogene Therapeutics, Inc.22.4MUS$35.9M0.89%
BioCryst Pharmaceuticals, Inc.4.01MUS$33.4M0.83%
Celldex Therapeutics, Inc.900KUS$29.2M0.72%
ACADIA Pharmaceuticals Inc.1.44MUS$29M0.72%
Shattuck Labs, Inc.3.75MUS$25.6M0.63%
Immunocore Holdings plc830KUS$25.1M0.62%
Design Therapeutics, Inc.1.81MUS$22.7M0.56%
Evolus, Inc. Common Stock2.63MUS$21M0.52%
Sarepta Therapeutics, Inc.1.07MUS$19.5M0.48%
Relay Therapeutics, Inc.1.02MUS$18.3M0.45%
Lexeo Therapeutics, Inc.4.82MUS$16.3M0.40%
Valneva SE2.29MUS$14.2M0.35%
Kailera Therapeutics, Inc.1.2MUS$13.7M0.34%
Monte Rosa Therapeutics, Inc.1MUS$11.9M0.30%
ORIC Pharmaceuticals, Inc.752KUS$10.1M0.25%
Autolus Therapeutics plc4.45MUS$8.63M0.21%
Savara, Inc.1.11MUS$5.75M0.14%
Xilio Therapeutics, Inc.423KUS$3.82M0.09%
TCGX Acquisition Corp.300KUS$3.75M0.09%
iBio, Inc.1.95MUS$2.31M0.06%
Ascendis Pharma A/S0US$00.00%
BridgeBio Pharma, Inc.0US$00.00%
Cytokinetics, Incorporated0US$00.00%

Source

Download original · View original at SEC

Related